Johnson & Johnson still maintains that talc does not cause cancer. Johnson & Johnson announced Wednesday that it plans to pay nearly $6.5 billion over 25 years to settle all pending and future U.S ...
May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
The offer is the company’s third attempt to resolve tens of thousands of claims that its baby powder caused ovarian cancer and mesothelioma.
Johnson & Johnson on Wednesday proposed a plan to pay nearly $6.5 billion to resolve tens of thousands of lawsuits claiming that its cosmetic talc-based powder causes cancer. Through a ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...
#Socialites, get into this: Johnson & Johnson, one of the world’s largest pharmaceutical companies, has announced its plan to pay a whopping $6.5 billion to settle the majority of the talc ovarian ...
Johnson & Johnson has allocated a reserve totaling $11 billion to accommodate talc-related settlements. The proposed settlement aims to address the majority of talc-related litigation regarding ...
Johnson & Johnson (NYSE:JNJ) shares popped on Wednesday, amid word the pharmaceutical giant will pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ...